BioCentury
ARTICLE | Clinical News

Vical preclinical data

August 2, 2010 7:00 AM UTC

In mice, Vical's prophylactic Vaxfectin-formulated plasmid DNA HSV-2 vaccine encoding the human herpes simplex type 2 (HSV-2) glycoprotein D antigen elicited antibody responses in 100% of mice, prote...